1-7 of 7
Preeti Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retraction: Aromatase Inhibitor–mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer

Raju Khatri, Preeti Shah, Rupa Guha, Feyruz V. Rassool, Alan E. Tomkinson, Angela Brodie, Anil K. Jaiswal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (11): 2491.
https://doi.org/10.1158/1535-7163.MCT-17-0310
Published: 02 November 2018
View article titled, Retraction: Aromatase Inhibitor–mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer
Open the PDF for Retraction: Aromatase Inhibitor–mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer in another window
Journal Articles

Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells

Amanda Schech, Armina Kazi, Stephen Yu, Preeti Shah, Gauri Sabnis
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (8): 1848–1857.
https://doi.org/10.1158/1535-7163.MCT-14-0778
Published: 05 August 2015
View article titled, Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
Open the PDF for Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Aromatase Inhibitor–Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer

Raju Khatri, Preeti Shah, Rupa Guha, Feyruz V. Rassool, Alan E. Tomkinson, Angela Brodie, Anil K. Jaiswal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7): 1728–1737.
https://doi.org/10.1158/1535-7163.MCT-14-0672
Published: 06 July 2015
View article titled, Aromatase Inhibitor–Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer
Open the PDF for Aromatase Inhibitor–Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2

Gauri J. Sabnis, Olga G. Goloubeva, Armina A. Kazi, Preeti Shah, Angela H. Brodie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (12): 2804–2816.
https://doi.org/10.1158/1535-7163.MCT-13-0345
Published: 05 December 2013
View article titled, HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2
Open the PDF for HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2 in another window
Includes: Supplementary data
Journal Articles

Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma

Leigh Ellis, Preeti Shah, Hans Hammers, Kristin Lehet, Paula Sotomayor, Gissou Azabdaftari, Mukund Seshadri, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 383–392.
https://doi.org/10.1158/1535-7163.MCT-11-0748
Published: 08 February 2012
View article titled, Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma
Open the PDF for Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma in another window
Journal Articles

Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

Hans J. Hammers, Henk M. Verheul, Brenda Salumbides, Rajni Sharma, Michelle Rudek, Janneke Jaspers, Preeti Shah, Leigh Ellis, Li Shen, Silvia Paesante, Karl Dykema, Kyle Furge, Bin T. Teh, George Netto, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1525–1535.
https://doi.org/10.1158/1535-7163.MCT-09-1106
Published: 09 June 2010
View article titled, Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
Open the PDF for Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study in another window
Journal Articles

Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer

Antonio Jimeno, Gurulingappa Hallur, Audrey Chan, Xiangfeng Zhang, George Cusatis, Fonda Chan, Preeti Shah, Rongbing Chen, Ernest Hamel, Elizabeth Garrett-Mayer, Saeed Khan, Manuel Hidalgo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1509–1516.
https://doi.org/10.1158/1535-7163.MCT-06-0592
Published: 18 May 2007
View article titled, Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein <em>tau</em> is predictive of their activity in pancreatic cancer
Open the PDF for Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein <em>tau</em> is predictive of their activity in pancreatic cancer in another window